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SUMMARY
We performed a systematic literature review to assess the effectiveness of chemoprophylaxis for
contacts of sporadic cases of invasive meningococcal disease (IMD) in educational settings. No
studies directly compared IMD risk in contacts with/without chemoprophylaxis. However,
compared to the background incidence, an elevated IMD risk was identified in settings without
a general recommendation for chemoprophylaxis in pre-schools [pooled risk difference (RD)
58.2/105, 95% confidence interval (CI) 27.3–89.0] and primary schools (pooled RD 4.9/105, 95%
CI 2.9–6.9) in the y30 days after contact with a sporadic IMD case, but not in other educational
settings. Thus, limited but consistent evidence suggests the risk of IMD in pre-school contacts of
sporadic IMD cases is significantly increased above the background risk, but lower than in
household contacts (pooled RD for household contacts with no chemoprophylaxis vs.
background incidence: 480.1/105, 95% CI 321.5–639.9). We recommend chemoprophylaxis for
pre-school contacts depending on an assessment of duration and closeness of contact.
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INTRODUCTION
Invasive meningococcal disease (IMD) in Europe for
the most part occurs as sporadic cases, with most
transmission leading to asymptomatic carriage [1]. In
several European studies investigating the proportion
of subsequent, epidemiologically linked cases, these
comprised 3–16% of all cases [2–6], with higher pro-
portions reported in higher incidence settings [3, 5, 6].
For instance, in Belgium the proportion of secondary
cases (including co-primary cases) was 5.2% in
1971–1973 and 2% in 1974–1976, with IMD inci-
dence decreasing from y5 to 1 IMD cases/100 000
inhabitants during 1971–1976 [3]. In Frediksborg
county, Denmark, the proportion of secondary cases
was 5–16% from 1987 to 1989, during which the
overall incidence was extremely high at between 9.7
and 14.1 [6]. While observational studies have shown
that chemoprophylaxis of household contacts of
persons with IMD to eradicate nasopharyngeal
carriage of Neisseria meningitidis reduces the risk of
subsequent cases in those contacts [7, 8], this has not
been shown for contacts in other settings, although
there are numerous reports on the occurrence of
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secondary cases in pre-school [2–5, 9–17], school
[2–5, 11, 17–30], and university or college settings
[2, 31–35]. Asymptomatic transmission of the index
strain has also been shown in these settings, although
to a lesser extent than in household settings [10, 16,
36, 37]. A survey of 12 European countries performed
in 2006 revealed variation in policy regarding
chemoprophylaxis for contacts between countries
as well as within countries over time [38]. This was
corroborated by unpublished data from a recent
survey [39], in which 12/28 European countries did
not recommend chemoprophylaxis for pre-school/
day-care contacts (referred to as pre-school from
hereon in) of a case of IMD while 16 did. Of these,
three recommended chemoprophylaxis for the entire
institution and 10 for contacts in the group or class of
the index patient (M. Hoek, personal communi-
cation). The lack of a common approach to policy
development in this area was in part attributed to
uncertainty around the effectiveness of preventive
measures [39]. Therefore, the European Centre for
Disease Prevention and Control (ECDC) launched
the development of guidance on the public health
management of sporadic cases of meningococcal dis-
ease. This involved systematic literature reviews and
the application of GRADE methodology [40–43] to
grade the evidence and strength of recommendations
[44]. In this paper, we present the results of a system-
atic literature search performed as part of this project
to search for direct and indirect evidence on the
effectiveness of chemoprophylaxis in educational
settings.
METHODS
We performed a systematic literature review looking
for direct and indirect evidence for the effectiveness of
chemoprophylaxis in pre-school, school and college
contacts of primary IMD cases. As a similar search in
2004 had not found any direct evidence [7], we pre-
sumed the focus would lie on indirect evidence.
Therefore, we specifically searched for data permit-
ting a comparison of the incidence of IMD in contacts
of primary cases in educational settings with the
background risk of sporadic cases. To enable an ex-
plicit comparison with risk in household settings, for
which there is direct evidence for the effectiveness
of chemoprophylaxis of close contacts [7], we also
searched for analogous data for household contacts
of sporadic IMD cases.
Search strategy
We searched the literature up to December 2009 in
Medline (from 1960), EMBASE (from 1974), Global
health (from 1972), Cochrane database of systematic
reviews and the Cochrane central register of con-
trolled trials through the German Institute of Medical
Documentation and Information (DIMDI, http://
www.dimdi.de/static/en/index.html). The following
search string was used to retrieve relevant papers :
(meningoc? OR neisseria meningit?) AND (chemo-
prev? OR ?prophyla? OR antibiotic?) AND (trans-
mission OR contact? OR second? OR attack OR
cluster? OR outbreak?) AND (?school? OR day care
OR nurser? OR child care OR college? OR universit?
OR dormitor?), yielding 310 abstracts. To search for
further, indirect evidence as described above, we
dropped the term (chemoprev? OR ?prophyla? OR
antibiotic?) and added the term AND (incidence or
risk) to identify any studies investigating subsequent
cases of meningococcal disease in contacts of primary
cases that would also allow comparison with the
background incidence of IMD. This yielded 386 ad-
ditional papers.
The following search string was used to identify
studies comparing the incidence of subsequent cases
in contacts in household settings with background
incidence: (meningoc? OR neisseria meningit?) AND
(transmission OR contact? OR second? OR attack
OR cluster? OR outbreak?) AND (household or
family). This yielded an additional 238 papers, for a
total of 934 retrieved references that were screened.
Inclusion and exclusion criteria
Papers in any European language were accepted. We
individually assessed abstracts for relevance to the
question and reviewed full papers on relevant ab-
stracts. Papers were selected for inclusion in the evi-
dence assessment if they described analytical or
observational studies with comparison groups or stud-
ies permitting comparison of incidence in contacts of
at least 10 cases in the defined settings with the back-
ground incidence of sporadic IMD cases. We exam-
ined reference lists in pertinent papers for other
relevant publications, and searched Google Scholar
for citations of identified key papers.
Identification of unpublished data
To minimize bias, epidemiologists and micro-
biologists with expertise in meningococcal disease
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across Europe were identified through established
Meningococcal Networks (Meningococcal Disease
Society, Invasive Bacterial Infections Network based
at ECDC) and asked for unpublished data that fitted
our criteria. However, no further studies were ident-
ified.
Comparison of IMD risk in contacts of primary cases
with background incidence of sporadic cases
In identified observational studies that provided in-
formation on subsequent cases of IMD in contacts of
index cases of IMD in pre-school, school, college or
household settings (see Appendix Table 1, available
online) we extracted or calculated the incidence of
subsequent cases in 1–30 days (or a period as close to
this as possible) after contact to the index case (sub-
sequent attack rate, SAR) in the retrieved studies for
household and educational settings. This was then
compared to the background age-specific incidence of
sporadic cases (ISC) in the same time interval by cal-
culating the relative risk (RR) and risk difference
(RD). The required parameters were calculated as
follows:
SAR=
total no: of subsequent cases
identified within defined time period
after occurrence of illness in index
cases in entire study period
total no: of contacts of primary




total no: of primary cases within
defined time period in study for






Taylor series 95% confidence intervals (CIs) for
RR were calculated using Epi-Info v. 6.04 and CIs for
RD were calculated based on the robust approxi-
mation of Miettinen & Nurminen [45] using an online
calculator provided by the University of Manchester
(http://www.phsim.man.ac.uk/risk/). Pooled risk
estimates were calculated using the METAN command
in Stata version 11.0 licensed to the Robert
Koch-Institute, including an analysis of heterogen-
eity between studies using the x2 test with a random-




Results of our search are summarized in Figure 1.
Direct evidence
Our search did not identify any direct evidence,
i.e. studies that compared the incidence of subsequent
cases in contacts given and not given chemoprophy-
laxis in educational settings.
Indirect evidence
A retrospective ecological study involving 12
European countries was identified in which countries
with a policy of giving chemoprophylaxis only to
close contacts after a single case of IMD in a pre-
school setting had 3.8 (95% CI 0.7–22.0) times the
risk of clusters than countries with a policy of giving
chemoprophylaxis to all children in the nursery [38].
There was a lack of accurate national statistics on the
size and number of nursery schools. Co-primary cases
were not excluded.
Our search strategy further identified seven obser-
vational studies that permitted comparison of IMD
incidence in contacts of primary cases in educational
settings with background incidence of sporadic IMD
cases [2–4, 11, 24, 30, 46] (Appendix Table 1). A total
of 15 observational studies (16 publications) [2–4, 11,
24, 30, 46–59] was identified with information on risk
of subsequent IMD in household contacts of sporadic
cases, of which only five contained all numerator and
denominator data required for a comparison of risk in
contacts who had not received chemoprophylaxis
with the background incidence of sporadic cases
(Appendix Table 5).
Risk of subsequent cases of IMD in contacts of
primary cases compared to background risk of
sporadic IMD
Pre-school setting
Five studies permitted estimation of risk in pre-school
settings [2–4, 11, 46]. In two studies in which chemo-
prophylaxis was recommended by public health
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authorities for contacts in the same pre-school as the
IMD case, no subsequent cases were observed [2, 4].
In the three other studies where chemoprophylaxis
was not generally recommended [3, 11, 46], the risk
of subsequent cases in contacts was significantly
higher than the background IMD incidence (Appendix
Table 2). The pooled estimates of RR and RD from
these studies, which fulfilled criteria for homogeneity,
were 22.3 (95% CI 12.1–40.9) and 58.2/105 (95% CI
27.3–89.0), respectively (Table 1).
School setting
Five studies permitted calculation of SAR, RR and
RD in various school settings (Appendix Table 3).
Chemoprophylaxis was not recommended for school
contacts in these settings, with the exception of close
contacts among classmates in France [4]. SAR was
generally lower than in pre-school settings with the
exception of the Brazilian study [26] (which was,
however, undertaken in a very high incidence setting
and therefore excluded from the pooled analysis) and
the French study [4], where SAR estimates in class-
room contacts overlapped with estimates in older pre-
school children in the UK [11] and Belgium [3]
(Appendix Tables 2 and 3). In the one study that in-
cluded both pre-school and school settings without
chemoprophylaxis [11] RR and RD were markedly
lower in school than nursery contacts (Appendix
Table 2). The RRs were consistently statistically sig-
nificantly elevated in all school-based studies, with a
wide range that overlapped with RRs in pre-school
settings. Because background incidences were lower
in school settings, however, the RDs were consistently
lower than in pre-school settings, with a pooled esti-
mate of 4.1/105 (95% CI 2.3–5.8) from one US [30]
and three European studies [2, 4, 11], but with sig-
nificant heterogeneity between these studies (Table 1).
When only data from primary-school children were
pooled (possible in three studies [2, 4, 11]), the RD
estimate was 4.9/105 (95% CI 2.9–6.9) and hetero-
geneity was no longer significant. When only data
from secondary-school children from these studies
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Fig. 1. Flowchart of search results. * One additional publication found in references; # two additional publications found in
references. IMD, Invasive meningococcal disease; SAR, subsequent attack rate.
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a RD estimate of 8.8/105 (95% CI –0.046 to 17.7). In
school settings, RR and RD were highest when
analyses were restricted to contacts in classrooms
[4, 24] (Appendix Table 3).
University setting
Only one study [11] provided data on risk of second-
ary cases in the university setting (Appendix Table 4).
The size of the contact group was very large (>5000)
and the SAR was only marginally higher than base-
line (RR 1.5, 95% CI 0.6–3.5).
Household setting
For comparison with the educational settings, in the
five household studies (Appendix Table 5) the pooled
RRs and RDs were 2254 (95% CI 947–5362) and
401/105 (95% CI 263–539), respectively (Table 1). The
observed substantial heterogeneity in the RR estimate
from these five studies was resolved by stratification,
leading to a more conservative estimate of RR of
1110.2 (95% CI 760.1–1621.4) but a slightly higher
RD of 480.1 (95% CI 321.5–639.9) when the two
studies with extremely high RR (and low number of
primary and secondary cases) [8, 56] were excluded
(Table 1).
Timing and exact setting of subsequent cases within
educational institutions
Exact data on the time interval between occurrence of
the primary and subsequent cases were not available
in all studies. Available data in two studies suggested
that about 70% of subsequent cases occurred within
1 week and 90–100% within 3 weeks [3, 11]. In the US
study in schools, 33% of subsequent cases occurred
within 1–2 days and 73% within 14 days [30].
Davison et al. [11] reported that 57% of all sub-
sequent cases occurred in the same grade or class
in pre-school and school settings combined, and
Zangwill et al. [30] reported that 55% of subsequent
cases were in a different grade than the index case.
DISCUSSION
Our search did not identify direct evidence for the ef-
fectiveness of chemoprophylaxis in contacts of IMD
in educational settings as no studies compared the
incidence of subsequent cases in treated and untreated
contacts. However, we found indirect evidence that
permitted a comparison of the risk of subsequent
cases in contacts of persons with IMD in educational
settings with the background risk in a defined time
interval of y30 days after occurrence of the index
case. Because direct evidence exists for the effective-
ness of chemoprophylaxis of contacts in household
settings, we also calculated the risk of subsequent
cases in household settings in contacts who did not
receive chemoprophylaxis and compared this to
background risk. Our study showed that contacts in
pre-school and school settings in which chemoprophy-
laxis was not generally recommended had a signifi-
cantly increased risk of IMD, but that this risk was
markedly lower than for household contacts.
The studies included in our analysis have a number
of limitations. While they applied directly to the popu-
lations of interest, background incidences varied.
Table 1. Pooled estimates of the relative risk (RR) and risk difference (RD) of incidence of subsequent invasive
meningococcal disease (IMD) cases in contacts at y1 month after contact with a case of IMD and background
IMD incidence (detailed data in online Appendix Tables 1–5)
Setting (references) RR 95% CI
Heterogeneity
(P) RD 95% CI
Heterogeneity
(P)
Pre-schools [3, 11, 46] 22.3 12.1 to 40.9 0.66 58.2 27.3 to 89.0 0.15
Schools (all) [2, 4, 11, 30] 26.2 12.5 to 54.8 <0.0001 4.1 2.3 to 5.8 0.007
Primary schools [2, 4, 11] 21.1 7.0 to 63.6 0.03 4.9 2.9 to 6.9 0.45
Secondary schools [2, 4, 11] 33.3 5.1 to 215.7 <0.0001 8.8 x0.5 to 17.7 0.004
Universities [2]* 1.5 0.6 to 3.5 —* 0.2 x0.2 to 0.6 —
Households [3, 4, 8, 56, 58, 60] 2106.7 988.1 to 4491.9 0.007 418.9 282.4 to 555.3 0.409
Stratified:
[3, 4, 60] 1110.2 760.1 to 1621.4 0.43 480.1 321.5 to 639.9 0.96
[8, 56] 6922.1 2694.6 to 17781.5 1.0 772.2 x1261.8 to 2806.1 0.19
* One study only.
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Active prospective follow-up of contacts to ascertain
subsequent cases was not performed in all household
studies (Appendix Table 1). All key studies in edu-
cational settings but one collected at least some of the
data retrospectively (Appendix Table 1) and lacked
data on potential confounding variables such as socio-
economic factors and other risk factors for IMD.
Some studies included co-primary cases [2, 11], which
would lead to an overestimation of SAR and RR. In
addition, the studies varied in the definition of the
time interval for ascertainment of subsequent cases,
which ranged from 28 days to 4 months. However, as
the risk of subsequent cases approaches the back-
ground risk after 3–4 weeks, the RR and RD would
tend to be lower by inclusion of studies with a longer
observation period. In all studies, the number of
contacts of primary cases was estimated based on
available national data on mean group or class size
and size of institutions and thus probably diverged
from the true situation in the few outbreaks that
occurred. Furthermore, calculation of SAR was often
based on very small numbers of subsequent cases
(sparse data), and the observed increased risk of IMD
in contacts vs. the background risk tended to be
higher in less precise studies with smaller numbers
of cases. Moreover, recognition of a case among
contacts may be more likely than in the general
population, thus background incidence may be under-
estimated and RR overestimated. However, as IMD
is such a severe disease, under-ascertainment of pri-
mary cases is likely to be lower than for many other
infections. Data were lacking on whether any contacts
actually obtained chemoprophylaxis ; information
was only given as to whether chemoprophylaxis was
generally recommended or not in the respective set-
ting when the study was undertaken. Receipt of anti-
biotics by contacts would lead to falsely low estimates
of SAR. Only three studies [2, 11, 30] provided data
on strain characterization of at least a proportion of
primary and subsequent cases ; these suggested that
meningococcal strains are identical in primary and
subsequent cases in most instances.
In view of these limitations it is, nonetheless, re-
markable that the evaluated studies consistently
showed a significantly increased risk for the occur-
rence of subsequent IMD cases compared to the
background incidence of primary cases in a time in-
terval from 0–2 to 28–120 days after illness onset in
the index case in pre-school and school settings where
chemoprophylaxis was not generally recommended.
Compared to background incidence, the risk of
acquiring IMD was significantly elevated in pre-
school settings (RD 58.2/105, 95% CI 27.3–89.0)
when chemoprophylaxis was not recommended. This
is underscored by the absence of subsequent cases
in pre-school contacts in settings with clear rec-
ommendations for chemoprophylaxis in place [2, 4].
In fact, in England and Wales, no subsequent cases of
IMD were observed in pre-school settings from 1992
to 1995, when chemoprophylaxis was recommended,
but were observed starting in 1995–1996, when this
recommendation was rescinded. While clusters due to
serogroup C did not occur after 1999–2000, when
mass vaccination against IMD due to serogroup C
took place in the UK [61], serogroup B clusters con-
tinued to be observed in educational settings [12, 62].
Our findings are also supported by an analysis of IMD
clusters in Barcelona from May 1995 to December
1997 [5], in which seven of the 13 observed clusters
occurred in nurseries [two occurred in schools, one in
siblings (family members received chemoprophylaxis
in 93.6% of cases), two in military settings and one in
members of the same village]. Our estimated RD for
pre-schools was an order of magnitude lower than
that for household settings (401/105, 95% CI
263–539), where chemoprophylaxis has been esti-
mated to decrease the risk of subsequent cases in
contacts by y86% [44]. Under the assumption that
chemoprophylaxis would be similarly effective in pre-
school settings, the number of contacts to be treated
(NNT) with an antibiotic to prevent one case can be
estimated as RD 1/0.86. Based on the above data, this
yields an estimate of 1998 (95% CI 1307–4259) chil-
dren, compared to 290 (95% CI 216–442) in house-
hold settings. Thus the cost of preventing one case
would be markedly higher than in households.
Furthermore, in educational settings it may take
longer or be more complex to arrange for all contacts
to receive antibiotics, thus the effectiveness of chemo-
prophylaxis may well be lower than in households.
While RR estimates overlapped, RD estimates in
school settings were an order of magnitude lower than
in pre-school settings, largely because the background
risk in older children was lower than in younger chil-
dren. Thus, NNT estimates would be markedly higher
still. The study in university settings was limited by
the large size of the contact group, which may have
made recognition of epidemiologically linked cases
more difficult ; defining smaller contact groups might
have led to higher estimates of SAR.
None of the studies included in the meta-analyses
mentioned educational workers. A review article on
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the risk of educational workers [63] listed only one
reference that identified teachers who contracted
IMD. In this study, which reviewed 50 adult IMD
cases ascertained from 1997 to 1999 in Cheshire, UK,
seven cases were identified in educational workers
with a sixfold higher risk compared to the general
adult working population [64]. The authors rec-
ommended caution in interpretation of these results
due to the small area investigated during a period of
increased incidence; however, the results suggest that
school workers should be included in the risk assess-
ment of contacts of IMD cases.
While a review of 18 studies did not find any reports
of severe adverse events in conjunction with anti-
microbial chemoprophylaxis with rifampicin, cipro-
pfloxacin, ceftriaxone or azithromyicin, mild side-
effects of recommended antibiotic regimens were
common [65]. A case of anaphylaxis and two anaphyl-
actoid reactions have been described in conjunction
with chemoprophylaxis using ciprofloxacin [65–67].
Thus severe side-effects may rarely occur, particularly
if the number of persons defined as contacts is large.
The development of resistance has been observed
in randomized controlled eradication trials with
rifampicin, with 10–27% of initial carriers developing
resistance in three randomized controlled trials [68–71].
Emergence and spread of rifampicin resistance has
also been observed in several non-controlled studies
[22, 48, 72, 73] and cases due to rifampicin-resistant
meningococcal isolates have also been reported after
prophylaxis [48, 74–77]. On the other hand, resistant
N. meningitidis has not spread widely, possibly
because the acquisition of rifampicin resistance
appears to confer a biological disadvantage [71].
Ciprofloxacin-resistant N. meningitidis was isolated in
the USA in 2009 from three IMD cases and two car-
riers, one after contact with one of the patients and
after receipt of ciprofloxacin [78] ; no further cases
have been described after recommendations to use
other antibiotics for prophylaxis in the affected re-
gions. Another theoretical negative effect of chemo-
prophylaxis is the eradication of N. lactamica from
the nasopharynx. Colonization of N. lactamica is as-
sociated with the induction of cross-protective
immunity to N. meningitides [79, 80]. Carriage of
N. lactamica is highest in nursery-aged children
[79, 81] and prior antibiotic therapy has been shown
to decrease carriage [81].
Because IMD is associated with a high risk of
complications and death its occurrence generates
substantial anxiety in contacts [82]. Thus we believe
that contacts would want chemoprophylaxis even if
evidence for benefit is weak, as direct harmful effects
are rare and further risks largely theoretical. This is in
keeping with comments from The Meningitis Trust, a
non-governmental organization in the UK with a
public helpline, that it is difficult to convince parents
of children attending the same nursery/playgroup as a
case that prophylaxis is not needed.
As described in detail elsewhere [44], GRADE
methodology was applied to the results of this review
after taking into account the above limitations and
after weighing the potential benefits and harms in
light of disease severity and risk in the settings. This
resulted in the recommendation that attending the
same pre-school as an IMD case should be considered
an indication for chemoprophylaxis, depending on
risk assessment. The risk assessment should take into
account duration and closeness of contact, as the risk
of further cases is likely to be higher in settings similar
to households, where risk of exposure to respiratory
droplets would be more likely. Some studies found
a higher risk for IMD in more crowded household
settings [51, 83–85] and crowded conditions were
described in several day-care-associated outbreaks in
the USA [13, 14]. Thus children in the same group as
the index case who have spent long periods in the
same room (e.g. full-time attendance, sharing meals,
napping together) are likely to be at higher risk than
children in a different group.
The results of this systematic review suggest that
attending the same school/college (including the same
class) as a first case of IMD should not in itself be
considered an indication for widespread chemoprophy-
laxis in contacts. Here also, the decision for whom
chemoprophylaxis is indicated should be based on an
assessment of whether household-like contact may
have occurred among school friends, e.g. spending
nights together. In two school outbreaks various
extracurricular activities or excursions were identified
as possible settings in which transmission may have
occurred [25, 27].
Regardless of whether they receive chemoprophy-
laxis, all contacts should be informed of early symp-
toms of disease and the importance of seeking
immediate medical advice, as failure to do so has been
described and re-introduction of the index strain
cannot be ruled out due to the large number of social
contacts involved in educational settings. Indirect
evidence is available suggesting that vaccination
of close contacts of index cases with IMD due to a
vaccine-preventable strain prevents late secondary
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cases [86], and thus post-exposure vaccination is
strongly recommended in the ECDC guidance docu-
ment [44]. Further prospective studies on the risk
of subsequent cases and the transmission of disease-
causing strains in educational settings are needed.
Prospective studies on the risk of subsequent cases in
contacts who receive and do not receive chemoprophy-
laxis may be feasible as an initiative involving several
countries with divergent public health policies.
In conclusion, we found limited but consistent
evidence that the risk of IMD in pre-school contacts
of sporadic cases is significantly increased above
the background risk in European settings. In ad-
dition, in two studies performed in settings with a
recommendation for prophylactic treatment of pre-
school contacts, no subsequent cases were observed.
This is in keeping with results of the retrospective
ecological study performed by Boccia et al. [38],
which suggested a lower risk of IMD clusters in
countries in which prophylaxis of pre-school contacts
was recommended compared to those without such a
recommendation, although the difference was not
statistically significant. Although direct evidence for
the effectiveness of chemoprophylaxis has only been
shown in household settings, where the risk of sub-
sequent cases is an order of magnitude higher, we
recommend chemoprophylaxis for pre-school con-
tacts based on an assessment of duration and close-
ness of contact. In school or college settings
chemoprophylaxis should be offered only when there
is evidence of close prolonged contact with the index
case.
NOTE
Supplementary material accompanies this paper
on the Journal’s website (http://journals.cambridge.
org/hyg).
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